ProCE Banner Activity

Striking a Balance: The Role of Glucagon Agonism to Improve Obesity and Metabolic Care


Learn essential information about the current obesity treatment landscape, the role of glucagon agonism in dual and triple agonist approaches, and considerations for patient care and counseling.

Released: June 19, 2024

Expiration: June 18, 2025



Jaime Almandoz

Jaime Almandoz, MD, MBA, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Domenica M. Rubino

Domenica M. Rubino, MD

Washington Center for Weight Management and Research
Arlington, Virginia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.